Intra-arterial Direct Prostaglandin Infusion Combined with Lower Limb Arterial Bypass Graft and Lumbar Sympathectomy for Treating Buerger's Disease
![]() |
Yie, Kil-Soo
(Department of Thoracic and Cardiovascular Surgery, College of Medicine, Kangwon National University, Clinical Research Institute of Kangwon National University Hospital)
Ryu, Se-Min (Department of Thoracic and Cardiovascular Surgery, College of Medicine, Kangwon National University, Clinical Research Institute of Kangwon National University Hospital) Cho, Seong-Joon (Department of Thoracic and Cardiovascular Surgery, College of Medicine, Kangwon National University, Clinical Research Institute of Kangwon National University Hospital) Lee, Seo-Young (Department of Neurology, College of Medicine, Kangwon National University, Clinical Research Institute of Kangwon National University Hospital) |
1 | Jeffry WO. Thromboangitis obliterans: rutherford. Vascular Surgery. 6th ed. Philadelphia: Elsevier Saunders Co. 2005. |
2 | De Giacomo T, Rendina EA, Venuta F. Thoracoscopic sympathectomy for symptomatic arterial obstruction of the upper extremities. Ann Thorac Surg 2002;74:885-8. DOI ScienceOn |
3 | Park JS, Kim KU. Buerger's disease in Korea. Korean J Vasc Surg 2005;21:105-12. |
4 | Matsushita M, Nishikimi N, Sakurai T, Nimura Y. Decrease in prevalence of Buerger's disease in Japan. Surgery 1998;124:498-502. DOI PUBMED ScienceOn |
5 | The European TAO Study Group. Oral iloprost in the treatment of thromboangitis obliterans (Buerger' s disease): a double-blind, radomised, placebo-controlled trail. Euro J Vasc Surg 1998;15:300-6. DOI ScienceOn |
6 | Shionoya S. Buerger's disease: Diagnosis and management. Cardiovasc Surg 1993;1:207-15. PUBMED |
7 | Okuda Y, Kitajima T. The effects of combined sympathetic block and intravascular infusion of prostaglandin E1 on brachial arterial blood flow in dogs. Anesth Analg 1999; 89:1514-6. DOI ScienceOn |
8 | Grant SM, Goa KL. Iloprost. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential on peripheral vascular disease, myocardial ischemia andd extracorporeal circulation procedures. Drugs 1992;43: 889-95. DOI ScienceOn |
![]() |